story of the week
Update on Clinical Development of Novel Oral Medications for Retinal Diseases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Current Opinion in Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Novel oral medications for retinal disease: an update on clinical development
Curr Opin Ophthalmol 2023 May 01;34(3)203-210, CMT DeBoer, R Agrawal, E RahimyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.